Impact of Cardiopulmonary Resuscitation of Donors on Days Alive and Out of Hospital after Orthotopic Heart Transplantation.
cardiopulmonary resuscitation
heart failure
heart transplantation
mortality
patient centered outcomes
quality of life
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
03 Jul 2022
03 Jul 2022
Historique:
received:
31
05
2022
revised:
30
06
2022
accepted:
01
07
2022
entrez:
9
7
2022
pubmed:
10
7
2022
medline:
10
7
2022
Statut:
epublish
Résumé
The number of patients waiting for heart transplantation (HTX) is increasing. Optimizing the use of all available donor hearts is crucial. While mortality seems not to be affected by donor cardiopulmonary resuscitation (CPR), the impact of donor CPR on days alive and out of hospital (DAOH) is unclear. This retrospective study included adults who underwent HTX at the University Hospital Duesseldorf, Germany from 2010-2020. Main exposure was donor-CPR. Secondary exposure was the length of CPR. The primary endpoint was DAOH at one year. A total of 187 patients were screened and 171 patients remained for statistical analysis. One-year mortality was 18.7%. The median DAOH at one year was 295 days (interquartile range 206-322 days). Forty-two patients (24.6%) received donor-CPR hearts. The median length of CPR was 15 (9-21) minutes. There was no significant difference in DAOH between patients with donor-CPR hearts versus patients with no-CPR hearts (CPR: 291 days (211-318 days) vs. no-CPR: 295 days (215-324 days); Donor CPR status and length of CPR are not associated with reduced DAOH at one year after HTX.
Sections du résumé
BACKGROUND
BACKGROUND
The number of patients waiting for heart transplantation (HTX) is increasing. Optimizing the use of all available donor hearts is crucial. While mortality seems not to be affected by donor cardiopulmonary resuscitation (CPR), the impact of donor CPR on days alive and out of hospital (DAOH) is unclear.
METHODS
METHODS
This retrospective study included adults who underwent HTX at the University Hospital Duesseldorf, Germany from 2010-2020. Main exposure was donor-CPR. Secondary exposure was the length of CPR. The primary endpoint was DAOH at one year.
RESULTS
RESULTS
A total of 187 patients were screened and 171 patients remained for statistical analysis. One-year mortality was 18.7%. The median DAOH at one year was 295 days (interquartile range 206-322 days). Forty-two patients (24.6%) received donor-CPR hearts. The median length of CPR was 15 (9-21) minutes. There was no significant difference in DAOH between patients with donor-CPR hearts versus patients with no-CPR hearts (CPR: 291 days (211-318 days) vs. no-CPR: 295 days (215-324 days);
CONCLUSIONS
CONCLUSIONS
Donor CPR status and length of CPR are not associated with reduced DAOH at one year after HTX.
Identifiants
pubmed: 35807139
pii: jcm11133853
doi: 10.3390/jcm11133853
pmc: PMC9267911
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
N Engl J Med. 2001 Nov 15;345(20):1435-43
pubmed: 11794191
Anesthesiology. 2019 Jul;131(1):84-93
pubmed: 31094760
Thorac Cardiovasc Surg. 2021 Sep;69(6):504-510
pubmed: 32674179
Resuscitation. 2017 Dec;121:151-157
pubmed: 28870718
Ann Thorac Surg. 2016 Sep;102(3):751-758
pubmed: 27173071
J Thorac Cardiovasc Surg. 2017 Mar;153(3):622-630
pubmed: 27938903
Curr Opin Organ Transplant. 2012 Oct;17(5):558-63
pubmed: 22890039
Br J Anaesth. 2019 Nov;123(5):664-670
pubmed: 31493848
ESC Heart Fail. 2022 Feb;9(1):695-703
pubmed: 34734490
ESC Heart Fail. 2021 Apr;8(2):1253-1262
pubmed: 33480186
Thorac Cardiovasc Surg. 2020 Jun;68(4):263-276
pubmed: 32408357
Heart. 2018 Jan;104(2):151-160
pubmed: 28855271
Herz. 2020 Aug;45(5):475-482
pubmed: 30191263
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
J Am Heart Assoc. 2021 Aug 3;10(15):e019655
pubmed: 34315285
J Heart Lung Transplant. 2013 Nov;32(11):1090-5
pubmed: 23994219
Am Heart J. 2011 Nov;162(5):900-6
pubmed: 22093207
Crit Care Med. 2021 Jul 1;49(7):1107-1117
pubmed: 33729722
Thorac Cardiovasc Surg. 2021 Apr;69(3):263-270
pubmed: 32035427
J Heart Lung Transplant. 2014 Apr;33(4):327-40
pubmed: 24661451
JACC Heart Fail. 2016 Sep;4(9):698-708
pubmed: 27179833